This study tested the hypothesis that lipopolysaccharide (LPS) lowers arterial pressure through two different mechanisms depending on the dose. Previously, we found that a low hypotensive dose of LPS (1 mg/kg) lowers arterial pressure by activating vagus nerve afferents. Here we report that hypotension evoked by high dose LPS (15 mg/kg) can be prevented by injecting lidocaine into the OVLT but not by vagotomy or inactivation of the NTS. The hypotension produced by both LPS doses was correlated with elevated extracellular norepinephrine concentrations in the POA and prevented by blocking alpha-adrenergic receptors. Thus, initiation of endotoxic hypotension is dose-related, mechanistically.
Introduction
Septic shock has been characterized as a systemic inflammatory response to bacterial infection accompanied by persistent hypotension, tissue hypoperfusion and inadequate cellular oxygen utilization (Vincent, 2008; Angus and van der Poll, 2013) . Although substantial progress has been made toward understanding the molecular pathophysiology of septic shock (Van Amersfoort et al., 2003; Angus and van der Poll, 2013; Bosmann and Ward, 2013; King et al., 2014) it continues to be a major cause of death and mortality rates remain unacceptably high (Martin et al., 2003; Jawad et al., 2012) . Hence, there is a pressing need for new therapeutic strategies for treating, or preventing, septic shock.
Although hypotension, per se, does not fully account for the pathogenesis of septic shock, certainly restoration of arterial pressure and microvascular blood flow with intravenous fluids and vasopressors is standard initial therapy (Angus and van der Poll, 2013; Vincent and De Backer, 2013) . Accordingly, treatments that prevent the initial fall in arterial pressure evoked by severe sepsis may, in theory, avoid some of its detrimental effects and reduce or eliminate requirements for resuscitation fluids and vasopressors. This consideration raises the question: What initiates the fall in arterial pressure during sepsis?
To address this question experimentally, we treated rats with lipopolysaccharide (LPS), a cell wall constituent of Gram-negative bacteria commonly used in experimental models of septic shock. It is often assumed that LPS lowers arterial pressure by stimulating the release of tumor necrosis factor-α (TNF-α) and other cytokines which act on the vasculature to produce vasodilation (Ulloa and Tracey, 2005). However, in earlier studies, we tested an alternative hypothesis; that endotoxic hypotension is initiated through a central mechanism (Yilmaz et al., 2008b ). This hypothesis is based on evidence that LPS causes fever through a central mechanism in which the preoptic area of the hypothalamus (POA) plays a pivotal role (Blatteis et al., 2005) . We found, as in the case of fever, that the fall in arterial pressure evoked by a relatively low hypotensive dose of LPS, 1 mg/kg i.v., could be prevented by microinjecting the local anesthetic lidocaine or the alpha-adrenergic receptor antagonist phentolamine into the POA of conscious or anesthetized rats (Yilmaz et al., 2008a,b) . Lipopolysaccharide administration also elevated extracellular norepinephrine (NE) concentrations in the POA (Villanueva et al., 2009) , which suggests that LPS initially lowers arterial pressure by stimulating NE release. Together, these results indicate that endotoxic hypotension is initiated by activation of adrenergic neurons in the POA.
These findings raise a second fundamental question, how does a peripheral signal from LPS stimulate NE release within the POA? This issue has been studied extensively with regard to LPS-induced fever. LPS Journal of Neuroimmunology 285 (2015) 94-100
